Identification and evaluation of anti Hepatitis C virus phytochemicals from Eclipta alba

Journal of Ethnopharmacology

Volumn 144, Issue 3, 2012, Pages 545-554

  Manvar, Dinesh ^a   Mishra, Mahesh ^b   Kumar, Suriender ^a   Pandey, Virendra N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Ganesh Ayurvedic Pharmacy   (India)

Author keywords

Apigenin; Fluorescence quenching; Hepatitis C virus; Luteolin; NS5B; RNA dependent RNA polymerase; Wedelolactone

Indexed keywords

4 HYDROXYBENZOIC ACID; APIGENIN; ECLIPTA ALBA EXTRACT; LUTEOLIN; PLANT EXTRACT; PROTOCATECHUIC ACID; RNA POLYMERASE; TETRAZOLIUM; WEDELOLACTONE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BIOASSAY; CELL CULTURE; DRUG CYTOTOXICITY; DRUG ISOLATION; ECLIPTA ALBA; FLUORESCENCE; FRACTIONATION; GEL CHROMATOGRAPHY; HEPATITIS C VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INDIA; NONHUMAN; PURIFICATION; REPLICON; RNA ISOLATION; TRADITIONAL MEDICINE; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; ECLIPTA; HEPACIVIRUS; HUMANS; PLANT EXTRACTS; RNA REPLICASE; RNA, VIRAL; VIRUS REPLICATION;

ECLIPTA PROSTRATA; HEPATITIS C VIRUS;

EID: 84870292860     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.09.036     Document Type: Article

References (35)

1. N. Ali, K.D. Tardif, and A. Siddiqui Cell-free replication of the hepatitis C virus subgenomic replicon Journal of Virology 76 2002 12001 12007
2. P.L. Beaulieu Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections Current Opinion in Investigational Drugs 8 2007 614 634
3. P. Benes, L. Knopfova, F. Trcka, A. Nemajerova, D. Pinheiro, K. Soucek, M. Fojta, and J. Smarda Inhibition of topoisomerase IIalpha: novel function of wedelolactone Cancer Letters 303 2011 29 38
4. I. Bougie, S. Charpentier, and M. Bisaillon Characterization of the metal ion binding properties of the hepatitis C virus RNA polymerase The Journal of Biological Chemistry 278 2003 3868 3875
5. S.J. Butcher, J.M. Grimes, E.V. Makeyev, D.H. Bamford, and D.I. Stuart A mechanism for initiating RNA-dependent RNA polymerization Nature 410 2001 235 240
6. T.C. Chou On the determination of availability of ligand binding sites in steady-state systems Journal of Theoretical Biology 65 1977 345 356
7. K. Datta, A.T. Singh, A. Mukherjee, B. Bhat, B. Ramesh, and A.C. Burman Eclipta alba extract with potential for hair growth promoting activity Journal of Ethnopharmacology 124 2009 450 456
8. J.A. DiMasi, R.W. Hansen, and H.G. Grabowski The price of innovation: new estimates of drug development costs Journal of Health Economics 22 2003 151 185
9. J. Ding, G. Polier, R. Köhler, M. Giaisi, P.H. Krammer, and M. Li-Weber Wogonin and related natural flavones overcome Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression Journal of Biological Chemistry 287 2012 641 649
10. L.C. Diogo, R.S. Fernandes, S. Marcussi, D.L. Menaldo, P.G. Roberto, P.V. Matrangulo, P.S. Pereira, S.C. Franca, S. Giuliatti, A.M. Soares, and M.V. Lourenco Inhibition of snake venoms and phospholipases A(2) by extracts from native and genetically modified Eclipta alba: isolation of active coumestans Basic & Clinical Pharmacology & Toxicology 104 2009 293 299
11. S.O. Duke, and R.N. Paul Development and fine structure of the glandular trichomes of Artemisia annua L International Journal of Plant Sciences 154 1993 107 118
12. S. Flowers, E.E. Biswas, and S.B. Biswas Conformational dynamics of DnaB helicase upon DNA and nucleotide binding: analysis by intrinsic tryptophan fluorescence quenching Biochemistry 42 2003 1910 1921
13. J.Q. Hang, Y. Yang, S.F. Harris, V. Leveque, H.J. Whittington, S. Rajyaguru, G. Ao-Ieong, M.F. McCown, A. Wong, A.M. Giannetti, S. Le Pogam, F. Talamas, N. Cammack, I. Najera, and K. Klumpp Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus The Journal of Biological Chemistry 284 2009 15517 15529
14. J.F. Hu, R. Patel, B. Li, E. Garo, G.W. Hough, M.G. Goering, H.D. Yoo, M. ONeil-Johnson, and G.R. Eldridge Anti-HCV bioactivity of pseudoguaianolides from Parthenium hispitum Journal of Natural Products 70 2007 604 607
15. A.V. Ivanov, A.N. Korovina, V.L. Tunitskaya, D.A. Kostyuk, V.O. Rechinsky, M.K. Kukhanova, and S.N. Kochetkov Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins Protein Expression and Purification 48 2006 14 23
16. N. Kaushik-Basu, A. Bopda-Waffo, T.T. Talele, A. Basu, P.R. Costa, A.J. da Silva, S.G. Sarafianos, and F. Noel Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors Nucleic Acids Research 36 2008 1482 1496
17. D.L. Klayman Qinghaosu (artemisinin): an antimalarial drug from China Science 228 1985 1049 1055
18. M. Kobori, Z. Yang, D. Gong, V. Heissmeyer, H. Zhu, Y.K. Jung, M.A. Gakidis, A. Rao, T. Sekine, F. Ikegami, C. Yuan, and J. Yuan Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex Cell Death and Differentiation 11 2004 123 130
19. E. Kodama, S. Shigeta, T. Suzuki, and E. De Clercq Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method Antiviral Research 31 1996 159 164
20. J.G. Mahdi, A.J. Mahdi, and I.D. Bowen The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential Cell Proliferation 39 2006 147 155
21. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, R. Reindollar, Z.D. Goodman, K. Koury, M. Ling, and J.K. Albrecht Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
22. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nature Review in Microbiology 5 2007 453 463
23. T. Murata, T. Ohshima, M. Yamaji, M. Hosaka, Y. Miyanari, M. Hijikata, and K. Shimotohno Suppression of hepatitis C virus replicon by TGF-beta Virology 331 2005 407 417
24. E. Palumbo Pegylated interferon and ribavirin treatment for hepatitis C virus infection Therapeutic Advances in Chronic Disease 2 2011 39 45
25. E.S. Pocas, D.V. Lopes, A.J. da Silva, P.H. Pimenta, F.B. Leitao, C.D. Netto, C.D. Buarque, F.V. Brito, P.R. Costa, and F. Noel Structure-activity relationship of wedelolactone analogues: structural requirements for inhibition of Na+, K+ -ATPase and binding to the central benzodiazepine receptor Bioorganic and Medicinal Chemistry 14 2006 7962 7966
26. G. Polier, J. Ding, B.V. Konkimalla, D. Eick, N. Ribeiro, R. Kohler, M. Giaisi, T. Efferth, L. Desaubry, P.H. Krammer, and M. Li-Weber Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1 Cell Death & Disease 2 2011 e182
27. S.J. Polyak, C. Morishima, V. Lohmann, S. Pal, D.Y. Lee, Y. Liu, T.N. Graf, and N.H. Oberlies Identification of hepatoprotective flavonolignans from silymarin Proceedings of National Academy of Sciences of the United States of America 107 2010 5995 5999
28. F. Poordad, J. McCone Jr.; B.R. Bacon, S. Bruno, M.P. Manns, M.S. Sulkowski, I.M. Jacobson, K.R. Reddy, Z.D. Goodman, N. Boparai, M.J. DiNubile, V. Sniukiene, C.A. Brass, J.K. Albrecht, and J.P. Bronowicki Boceprevir for untreated chronic HCV genotype 1 infection New England Journal of Medicine 364 2011 1195 1206
29. S. Raimondi, S. Bruno, M.U. Mondelli, and P. Maisonneuve Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis Journal of Hepatology 50 2009 1142 1154
30. B. Singh, A.K. Saxena, B.K. Chandan, S.G. Agarwal, and K.K. Anand In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves Indian Journal of Physiological Pharmacology 45 2001 435 441
31. B. Singh, A.K. Saxena, B.K. Chandan, S.G. Agarwal, M.S. Bhatia, and K.K. Anand Hepatoprotective effect of ethanolic extract of Eclipta alba on experimental liver damage in rats and mice Phytotherapy Research 7 1993 154 158
32. H. Wagner, and G. Ulrich-Merzenich Synergy research: approaching a new generation of phytopharmaceuticals Phytomedicine 16 2009 97 110
33. R.B. Woodward, and W.E. Doering The total synthesis of quinine1 Journal of the American Chemical Society 66 1944 849 -849
34. S. Zeuzem, P. Andreone, S. Pol, E. Lawitz, M. Diago, S. Roberts, R. Focaccia, Z. Younossi, G.R. Foster, A. Horban, P. Ferenci, F. Nevens, B. Mullhaupt, P. Pockros, R. Terg, D. Shouval, B. van Hoek, O. Weiland, R. Van Heeswijk, S. De Meyer, D. Luo, G. Boogaerts, R. Polo, G. Picchio, and M. Beumont Telaprevir for retreatment of HCV infection New England Journal of Medicine 364 2011 2417 2428
35. Z. Zhang, D. Harris, and V.N. Pandey The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus Journal of Virology 82 2008 5761 5773